Legal Representation
Attorney
Hun Joon Kim
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-03-26)
Due Date
March 26, 2025
Grace Period Ends
September 26, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 30, 2025 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | Loading... |
| Jun 30, 2025 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | Loading... |
| Jun 30, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Mar 17, 2025 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Mar 26, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Feb 26, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 26, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 26, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 3, 2021 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Aug 16, 2019 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jul 31, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jul 30, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jun 26, 2019 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Mar 26, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 8, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 8, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 19, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 16, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 9, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 8, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 8, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 1, 2018 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 10, 2018 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 10, 2018 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 29, 2018 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 28, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 28, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 24, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 24, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 19, 2018 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Conducting technical project studies, namely, conducting clinical trials for others; research and development of new products for others; testing, inspection, or research of pharmaceuticals, cosmetics or foodstuff; research relating to pharmaceuticals; medical research services; research and development of technology for medicinal chemical manufacturing; product research for medical products; providing information on the test, inspection, or research of medical products; research and development in the pharmaceutical and biotechnology fields; pharmaceutical product evaluation; medical product testing; research relating to biotechnology; development of biotechnology; biotechnology services; biochemistry research services; biochemical analysis; development and test of chemical production methods; chemistry services; chemical research
Additional Information
Color Claim
The color(s) red and orange is/are claimed as a feature of the mark.
Other
The mark consists of the letters "SK" in red stylized font and "biopharmaceuticals" in orange stylized font; to the top right of the "SK" is a design of wings; the inner portion of the wings is red, and the outer portion of the wings is orange; white is not claimed as a feature of the mark and only represents background or transparent areas.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMACEUTICALS"